Lonza Group (XSWX:LONNE) 3-Year Revenue Growth Rate : 14.70% (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Lonza Group 3-Year Revenue Growth Rate?

Lonza Group's Revenue per Share for the six months ended in Jun. 2024 was CHF42.84.

During the past 12 months, Lonza Group's average Revenue per Share Growth Rate was 8.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 14.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Lonza Group was 14.70% per year. The lowest was -8.00% per year. And the median was 3.50% per year.

Competitive Comparison of Lonza Group's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Lonza Group's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lonza Group's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lonza Group's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Lonza Group's 3-Year Revenue Growth Rate falls into.

Lonza Group 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Lonza Group (XSWX:LONNE) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Lonza Group 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Lonza Group's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Lonza Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (XSWX:LONNE) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

LZAGY:USA LZAGF:USA LONN:Mexico LONNz:UK 0QNO:UK LO3A:Germany LONN:Switzerland

Address

Muenchensteinerstrasse 38, Basel, CHE, CH-4002

Website

https://www.lonza.com

Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

Lonza Group Headlines

No Headlines